OBJECTIVE: Moderate alcohol consumption has antiinflammatory properties and is associated with reduced cardiovascular disease and rheumatoid arthritis risks. We investigated the association between alcohol consumption and systemic lupus erythematosus (SLE) risk among women followed in the Nurses' Health Study (NHS) cohorts. METHODS: We conducted a prospective cohort analysis among 204,055 women in NHS (1980-2012) and NHSII (1989-2011) who were free of connective tissue disease and provided alcohol information at baseline. Alcohol consumption was assessed using a semiquantitative food frequency questionnaire every 2-4 years. We validated incident SLE through medical record review after self-report. Cox proportional hazards models estimated hazard ratios (HRs) for SLE based on cumulative average alcohol intake, adjusting for potential confounders. Results were meta-analyzed using DerSimonian and Laird random-effects models. We further investigated SLE risk associated with wine, beer, and liquor intake. RESULTS: We identified 125 incident SLE cases in NHS and 119 in NHSII. Mean ± SD age at SLE diagnosis was 55.8 ± 9.5 years in NHS and 43.4 ± 7.7 years in NHSII. Compared to no alcohol intake, the meta-analyzed multivariable HR for cumulative alcohol consumption ≥5 gm/day was 0.61 (95% confidence interval [95% CI] 0.41-0.89). When limiting alcohol exposure to >4 years prior to SLE diagnosis, the multivariable HR was similar: 0.61 (95% CI 0.41-0.91). Women who drank ≥2 servings/week of wine had significantly decreased SLE risk (HR 0.65, 95% CI 0.45-0.96) compared to women who did not drink wine. CONCLUSION: In these large prospective cohorts, we demonstrated an inverse association between moderate alcohol consumption (≥5 grams or 0.5 drink/day) and SLE risk in women.
OBJECTIVE: Moderate alcohol consumption has antiinflammatory properties and is associated with reduced cardiovascular disease and rheumatoid arthritis risks. We investigated the association between alcohol consumption and systemic lupus erythematosus (SLE) risk among women followed in the Nurses' Health Study (NHS) cohorts. METHODS: We conducted a prospective cohort analysis among 204,055 women in NHS (1980-2012) and NHSII (1989-2011) who were free of connective tissue disease and provided alcohol information at baseline. Alcohol consumption was assessed using a semiquantitative food frequency questionnaire every 2-4 years. We validated incident SLE through medical record review after self-report. Cox proportional hazards models estimated hazard ratios (HRs) for SLE based on cumulative average alcohol intake, adjusting for potential confounders. Results were meta-analyzed using DerSimonian and Laird random-effects models. We further investigated SLE risk associated with wine, beer, and liquor intake. RESULTS: We identified 125 incident SLE cases in NHS and 119 in NHSII. Mean ± SD age at SLE diagnosis was 55.8 ± 9.5 years in NHS and 43.4 ± 7.7 years in NHSII. Compared to no alcohol intake, the meta-analyzed multivariable HR for cumulative alcohol consumption ≥5 gm/day was 0.61 (95% confidence interval [95% CI] 0.41-0.89). When limiting alcohol exposure to >4 years prior to SLE diagnosis, the multivariable HR was similar: 0.61 (95% CI 0.41-0.91). Women who drank ≥2 servings/week of wine had significantly decreased SLE risk (HR 0.65, 95% CI 0.45-0.96) compared to women who did not drink wine. CONCLUSION: In these large prospective cohorts, we demonstrated an inverse association between moderate alcohol consumption (≥5 grams or 0.5 drink/day) and SLE risk in women.
Authors: Glinda S Cooper; Mary Anne Dooley; Edward L Treadwell; E William St Clair; Gary S Gilkeson Journal: J Clin Epidemiol Date: 2002-10 Impact factor: 6.437
Authors: S Sam Lim; A Rana Bayakly; Charles G Helmick; Caroline Gordon; Kirk A Easley; Cristina Drenkard Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Yvette C Cozier; Medha Barbhaiya; Nelsy Castro-Webb; Carolyn Conte; Sara K Tedeschi; Cianna Leatherwood; Karen H Costenbader; Lynn Rosenberg Journal: Arthritis Care Res (Hoboken) Date: 2019-05 Impact factor: 4.794
Authors: Christine G Parks; Aline de Souza Espindola Santos; Medha Barbhaiya; Karen H Costenbader Journal: Best Pract Res Clin Rheumatol Date: 2017-10-21 Impact factor: 4.098
Authors: Jill Hahn; Cianna Leatherwood; Susan Malspeis; Xinyi Liu; Bing Lu; Andrea L Roberts; Jeffrey A Sparks; Elizabeth W Karlson; Candace H Feldman; Melissa E Munroe; Judith A James; Laura D Kubzansky; Karen H Costenbader Journal: Lupus Date: 2020-06-06 Impact factor: 2.911
Authors: Andrea L Roberts; Susan Malspeis; Laura D Kubzansky; Candace H Feldman; Shun-Chiao Chang; Karestan C Koenen; Karen H Costenbader Journal: Arthritis Rheumatol Date: 2017-10-12 Impact factor: 10.995
Authors: Sara K Tedeschi; Medha Barbhaiya; Susan Malspeis; Bing Lu; Jeffrey A Sparks; Elizabeth W Karlson; Walter Willett; Karen H Costenbader Journal: Semin Arthritis Rheum Date: 2017-05-25 Impact factor: 5.532
Authors: Candace H Feldman; Susan Malspeis; Cianna Leatherwood; Laura Kubzansky; Karen H Costenbader; Andrea L Roberts Journal: J Rheumatol Date: 2019-05-15 Impact factor: 4.666
Authors: S K Tedeschi; M Barbhaiya; J A Sparks; E W Karlson; L D Kubzansky; A L Roberts; W C Willett; B Lu; K H Costenbader Journal: Lupus Date: 2019-11-13 Impact factor: 2.911
Authors: Medha Barbhaiya; Sara K Tedeschi; Bing Lu; Susan Malspeis; David Kreps; Jeffrey A Sparks; Elizabeth W Karlson; Karen H Costenbader Journal: Ann Rheum Dis Date: 2017-10-07 Impact factor: 19.103
Authors: Rebecca B Lawn; Kristen M Nishimi; Yongjoo Kim; Sun Jae Jung; Andrea L Roberts; Jennifer A Sumner; Rebecca C Thurston; Lori B Chibnik; Eric B Rimm; Andrew D Ratanatharathorn; Shaili C Jha; Karestan C Koenen; Shelley S Tworoger; Laura D Kubzansky Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-21 Impact factor: 4.254